{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:18:37Z","timestamp":1790313517284,"version":"4.1.0"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hypoparathyroidism is a rare endocrine disorder characterized by deficient secretion of parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, and impaired mineral homeostasis. Although most cases are postsurgical, the disease encompasses a heterogeneous group of etiologies, including genetic, autoimmune, and infiltrative causes. For much of its history, hypoparathyroidism was considered unique among endocrine deficiencies in that it was not treated with hormone replacement, owing to limited understanding of parathyroid physiology and the absence of safe and effective PTH-based therapies. This review provides a historical perspective on the evolution of hypoparathyroidism, from the anatomical discovery of the parathyroid glands in the nineteenth century to recent advances in molecular biology, laboratory diagnostics, and targeted treatments. Key milestones include the elucidation of calcium and phosphate regulation, the isolation and characterization of PTH, the identification of the calcium-sensing receptor, and the discovery of regulatory pathways involving fibroblast growth factor 23 and klotho. Parallel advances in clinical chemistry enabled increasingly accurate measurement of serum calcium and PTH, facilitating improved diagnosis and disease monitoring. Therapeutic strategies have evolved from conventional treatment with calcium and active vitamin D toward physiological hormone replacement. Clinical development of recombinant PTH formulations, long-acting prodrugs, and novel receptor agonists has transformed the therapeutic landscape and renewed interest in disease-modifying approaches. Emerging therapies, including oral agents, long-acting formulations, and cell-based strategies, suggest that the management of hypoparathyroidism is entering a new era focused on restoring physiological mineral metabolism and improving long-term outcomes.<\/jats:p>","DOI":"10.3389\/fendo.2026.1769262","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:25:15Z","timestamp":1775017515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypoparathyroidism: a brief historical overview for clinicians"],"prefix":"10.3389","volume":"17","author":[{"given":"Juan J.","family":"D\u00edez","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda","place":["Majadahonda, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Puerta de Hierro Segovia de Arana","place":["Majadahonda, Spain"]},{"name":"Department of Medicine, Universidad Aut\u00f3noma de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: Summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02014-8","article-title":"Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis","volume":"66","author":"D\u00edez","year":"2019","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf222","article-title":"Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of chronic hypoparathyroidism in adults","volume":"193","author":"Bollerslev","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1469-7998.1862.tb08046.x","article-title":"On the anatomy of the Indian rhinoceros (Rh. unicornis, L.)","author":"Owen","year":"1852","journal-title":"Zool Soc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90447-6","article-title":"A history of the parathyroid glands","volume":"26","author":"Eknoyan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2015.1027426","article-title":"The Uppsala anatomist Ivar Sandstr\u00f6m and the parathyroid gland","volume":"120","author":"Johansson","year":"2015","journal-title":"Ups J Med Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.24875\/CIRU.20001307","article-title":"El \u00faltimo descubrimiento anat\u00f3mico: las gl\u00e1ndulas paratiroides o Glandulae parathyroideae de Owen-Sandstr\u00f6m-Grey","volume":"90","author":"Ortiz-Hidalgo","year":"2022","journal-title":"Cir Cir"},{"key":"B11","article-title":"On a new gland in man and several mammals \u2013 glandulae parathyroideae","volume":"15","author":"Sandstr\u00f6m","year":"","journal-title":"Upsala L\u00e4k F\u00f6renings F\u00f6rh"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199609000-00010","article-title":"The glandulae parathyroideae of Ivar Sandstr\u00f6m. Contributions from two continents","volume":"20","author":"Carney","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"B13","article-title":"Sur la toxicit\u00e9 des urines des chiens thyroidectomis\u00e9s: contribution \u00e0 l\u2019\u00e9tude des fonctions du corps thyroide Comptes Rendus de la Societ\u00e9 de Biologie","volume":"3","author":"Gley","year":"1891"},{"key":"B14","article-title":"Sugli effeti dell\u2019estirpazione delle ghiandole paratiroide","volume":"1","author":"Vassale","year":"1896","journal-title":"Riv Pat Nerv Ment"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.1622.215","article-title":"Remarks on the function of the thyroid gland: a critical and historical review","volume":"1","author":"Horsley","year":"1892","journal-title":"Br Med J"},{"key":"B16","article-title":"Hyperparathyroidism: retrospect and prospect","volume":"58","author":"Taylor","year":"1976","journal-title":"Ann R Coll Surg Engl"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/jhmas\/42.2.186","article-title":"A gland in a search of a function: the parathyroid glands and the explanations of tetany 1903-1926","volume":"42","author":"Dolev","year":"1987","journal-title":"J Hist Med Allied Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20.2.149","article-title":"The removal of calcium from the blood by dialysis in the study of tetany","volume":"20","author":"Maccallum","year":"1914","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.11.1.118","article-title":"On the relation of tetany to the parathyroid glands and to calcium metabolism","volume":"11","author":"Maccallum","year":"1909","journal-title":"J Exp Med"},{"key":"B20","article-title":"An elementary chemical study of the parathyroid glands of cattle","volume":"53","author":"Hanson","year":"1923","journal-title":"Mil Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s0021-9258(18)85007-4","article-title":"The extraction of parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium","volume":"63","author":"Collip","year":"1925","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jocd.2012.11.002","article-title":"A short history of parathyroid hormone, its biological role, and pathophysiology of hormone excess","volume":"16","author":"Potts","year":"2013","journal-title":"J Clin Densitom"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1021\/ja01527a066","article-title":"Purification of parathormone by use of countercurrent distribution","volume":"81","author":"Rasmussen","year":"1959","journal-title":"J Am Chem Soc"},{"key":"B25","article-title":"The discovery of the parathyroid glands","volume":"56","author":"O\u2019Rahilly","year":"1982","journal-title":"Bull Hist Med"},{"key":"B26","first-page":"398","article-title":"On osteitis deformans without bony tissue","volume-title":"Arbeiten aus dem pathologisch-anatomischen Institut zu T\u00fcbingen","author":"Askanazy","year":"1903"},{"key":"B27","first-page":"1362","article-title":"Two cases of parathyroid tumor","volume":"28","author":"Schlagenhaufer","year":"1915","journal-title":"Wien Klin Wochenschr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-192910000-00027","article-title":"Parathyroidectomy in osteomalacia","volume":"90","author":"Richardson","year":"1929","journal-title":"Ann Surg"},{"key":"B29","first-page":"394","article-title":"Hyperparathyroidism; a review of historical developments and the present state of knowledge on the subject","volume":"21","author":"Mandl","year":"1947","journal-title":"Surgery"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1934.02750160010003","article-title":"Hyperparathyroidism epitomized: the case of Captain Charles E. Martell","volume":"11","author":"Bauer","year":"1962","journal-title":"Metabolism"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s1072-7515(00)00347-1","article-title":"The history of parathyroid surgery, 1850-1996: the Excelsior Surgical Society 1998 Edward D Churchill Lecture","volume":"191","author":"Organ","year":"2000","journal-title":"J Am Coll Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215109005702","article-title":"History of parathyroid gland surgery: an historical case series","volume":"123","author":"Giddings","year":"2009","journal-title":"J Laryngol Otol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.07.004","article-title":"Epidemiology and complications of hypoparathyroidism","volume":"47","author":"Clarke","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4714","article-title":"Etiology and pathophysiology of hypoparathyroidism: a narrative review","volume":"37","author":"Pasieka","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01075-8","article-title":"Hypoparathyroidism: diagnosis, management and emerging therapies","volume":"21","author":"Khan","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B36","first-page":"11","article-title":"Zur Kinderheilkunde in K\u00f6nigsberg\/Preu\u00dfen in Lehre, Praxis und Forschung Personelle, institutionengeschichtliche und krankheitsspezifische Aspekte (Mitte des 19. Jahrhunderts bis 1945)","volume-title":"Medizin, Gesellschaft und Geschichte","author":"Hinz","year":"2025"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: Pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and hypoparathyroid disorders","volume":"343","author":"Marx","year":"2000","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1958.00260180133014","article-title":"Idiopathic hypoparathyroidism","volume":"101","author":"Saphir","year":"1958","journal-title":"AMA Arch Intern Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1929.01930080104011","article-title":"Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years","volume":"38","author":"Thorpe","year":"1929","journal-title":"Am J Dis Child"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","article-title":"The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)","volume":"17","author":"Guo","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198109000-00003","article-title":"Two types of autoimmune Addison\u2019s disease associated with different polyglandular autoimmune (PGA) syndromes","volume":"60","author":"Neufeld","year":"1981","journal-title":"Med (Baltimore)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.606860","article-title":"Autoimmune Addison\u2019s disease as part of the autoimmune polyglandular syndrome type 1: historical overview and current evidence","volume":"12","author":"Perniola","year":"2021","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1021\/bi00706a033","article-title":"The amino acid sequence of bovine parathyroid hormone I","volume":"351","author":"Niall","year":"1970","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.67.4.1862","article-title":"Bovine parathyroid hormone: amino acid sequence","volume":"67","author":"Brewer","year":"1970","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.1.63","article-title":"Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone","volume":"68","author":"Potts","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.2.384","article-title":"The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone","volume":"71","author":"Niall","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1021\/bi00619a019","article-title":"Complete amino acid sequence of human parathyroid hormone","volume":"17","author":"Keutmann","year":"1978","journal-title":"Biochemistry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1515\/bchm2.1974.355.1.415","article-title":"Solid-phase synthesis of the biologically active N-terminal 1\u201334 peptide of human parathyroid hormone","volume":"355","author":"Tregear","year":"1974","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.12.3585","article-title":"Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34","volume":"69","author":"Brewer","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1021\/bi00680a006","article-title":"A reinvestigation of the amino-terminal sequence of human parathyroid hormone","volume":"14","author":"Keutmann","year":"1975","journal-title":"Biochemistry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1402.088","article-title":"Progress, paradox, and potential: parathyroid hormone research over five decades","volume":"1117","author":"Potts","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801027105","article-title":"Molecular recognition of parathyroid hormone by its G protein-coupled receptor","volume":"105","author":"Pioszak","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-018-0151-4","article-title":"High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist","volume":"25","author":"Ehrenmann","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7942","article-title":"Structure and dynamics of the active human parathyroid hormone receptor-1","volume":"364","author":"Zhao","year":"2019","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/j.molcel.2022.07.003","article-title":"Endogenous ligand recognition and structural transition of a human PTH receptor","volume":"82","author":"Kobayashi","year":"2022","journal-title":"Mol Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/209052a0","article-title":"Evaluation by radioimmunoassay of factors controlling the secretion of parathyroid hormone","volume":"209","author":"Sherwood","year":"1966","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.82.2.269","article-title":"Depolarizing response of rat parathyroid cells to divalent cations","volume":"82","author":"L\u00f3pez-Barneo","year":"1983","journal-title":"J Gen Physiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)81029-3","article-title":"High extracellular Ca2+ and Mg2+ stimulate accumulation of inositol phosphates in bovine parathyroid cells","volume":"218","author":"Brown","year":"1987","journal-title":"FEBS Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-1-382","article-title":"High calcium and other divalent cations increase inositol trisphosphate in bovine parathyroid cells","volume":"123","author":"Shoback","year":"1988","journal-title":"Endocrinology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(18)61172-x","article-title":"Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor","volume":"262","author":"Nemeth","year":"1987","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4160(90)90032-p","article-title":"The role of extracellular calcium in the regulation of intracellular calcium and cell function","volume":"11","author":"Nemeth","year":"1990","journal-title":"Cell Calcium"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/er.2009-0043","article-title":"The calcium-sensing receptor: a molecular perspective","volume":"32","author":"Magno","year":"2011","journal-title":"Endocr Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1124\/pr.119.018531","article-title":"International union of basic and clinical pharmacology. CVIII. Calcium-sensing receptor nomenclature, pharmacology, and function","volume":"72","author":"Leach","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2014.09.005","article-title":"New insights into the FGF23-Klotho axis","volume":"34","author":"Olauson","year":"2014","journal-title":"Semin Nephrol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.218","article-title":"Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism","volume":"8","author":"Quarles","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00926-x","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphatemia","volume":"21","author":"Haffner","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031260","article-title":"Biology of fibroblast growth factor 23: from physiology to pathology","volume":"8","author":"Courbebaisse","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1530\/JME-20-0178","article-title":"FGF23 signaling and physiology","volume":"66","author":"Ho","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32409","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"21","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1565-3","article-title":"FGF23 and the parathyroid glands","volume":"25","author":"Silver","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.744052","article-title":"Convergent signaling pathways regulate parathyroid hormone and fibroblast growth factor-23 action on NPT2A-mediated phosphate transport","volume":"291","author":"Sneddon","year":"2016","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00223-017-0333-9","article-title":"Fibroblast growth factor (FGF) 23 regulates the plasma levels of parathyroid hormone In Vivo through the FGF receptor in normocalcemia, but not in hypocalcemia","volume":"102","author":"Mace","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328303e172","article-title":"Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion","volume":"17","author":"Galitzer","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00665-x","article-title":"Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions","volume":"19","author":"Agoro","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4429","article-title":"PTH and FGF23 exert interdependent effects on renal phosphate handling: evidence from patients with hypoparathyroidism and hyperphosphatemic familial tumoral calcinosis treated with synthetic human PTH 1-34","volume":"37","author":"Ovejero","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050718","article-title":"Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2016.02.001","article-title":"The FGF23\/KLOTHO regulatory network and its roles in human disorders","volume":"101","author":"Kinoshita","year":"2016","journal-title":"Vitam Horm"},{"key":"B86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","author":"Kuro-O","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.10.052","article-title":"The Klotho gene family as a regulator of endocrine fibroblast growth factors","volume":"299","author":"Kurosu","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.33594\/000000797","article-title":"Regulation of \u03b1Klotho","volume":"59","author":"Vogt","year":"2025","journal-title":"Cell Physiol Biochem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1079","article-title":"Molecular basis of Klotho: from gene to function in aging","volume":"36","author":"Xu","year":"2015","journal-title":"Endocr Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-009-0722-7","article-title":"Klotho","volume":"459","author":"Kuro-o","year":"2010","journal-title":"Pflugers Arch"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1177\/000456327601300156","article-title":"Measurement of ionized calcium in body fluids-a review","volume":"13","author":"Robertson","year":"1976","journal-title":"Ann Clin Biochem"},{"key":"B92","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1258\/acb.2009.008099","article-title":"Development of a new measurement method for serum calcium with chlorophosphonazo-III","volume":"46","author":"Hokazono","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/42.8.1202","article-title":"New enzymatic assay for calcium in serum","volume":"42","author":"Kimura","year":"1996","journal-title":"Clin Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/66.4.619","article-title":"Comparison of serum calcium measurements with respect to five models of atomic absorption spectrometers using NBS-AACC calcium reference method and isotope-dilution mass spectrometry as the definitive method","volume":"66","author":"Copeland","year":"1976","journal-title":"Am J Clin Pathol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0175","article-title":"Determination of serum calcium levels by 42Ca isotope dilution inductively coupled plasma mass spectrometry","volume":"56","author":"Han","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.235109","article-title":"Inductively coupled plasma mass spectrometry as a reference method to evaluate serum calcium measurement bias and the commutability of processed materials during routine measurements","volume":"131","author":"Zhao","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","volume":"49","author":"Berson","year":"1963","journal-title":"Proc Natl Acad Sci USA"},{"key":"B98","article-title":"Immunoassays for the detection of parathyroid hormone","volume":"17","author":"J\u00fcppner","year":"2002","journal-title":"J Bone Miner Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022010036","article-title":"High-resolution mass spectrometry for the measurement of PTH and PTH fragments: insights into PTH physiology and bioactivity","volume":"33","author":"Ulmer","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4158\/EP10297.RA","article-title":"The parathyroid hormone assay","volume":"17","author":"Rodgers","year":"2011","journal-title":"Endocr Pract"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-0942","article-title":"Determination of parathyroid hormone: from radioimmunoassay to LCMS\/MS","volume":"61","author":"Cavalier","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(75)90138-2","article-title":"Technique de dosage radioimmunologique de la parathormone humaine. Utilization d\u2019un antiserum disponible et d\u2019un etalon international [Radio-immunoassay method for determination of parathyroid hormone. Use of a commercially available antiserum and an international standard (author\u2019s transl)","volume":"64","author":"Mallet","year":"1975","journal-title":"Clin Chim Acta"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvac135","article-title":"Validation of an LC-MS\/MS method using solid-phase extraction for the quantification of 1\u201384 parathyroid hormone: Toward a candidate reference measurement procedure","volume":"68","author":"Farr\u00e9-Segura","year":"2022","journal-title":"Clin Chem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.033","article-title":"Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease","volume":"105","author":"Cavalier","year":"2024","journal-title":"Kidney Int"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5c03332","article-title":"Antibody-free inline dual-retention nano-WCX-\u03bcSPE-MS\/MS for quantification of intact parathyroid hormone and antagonistic fragments in clinical serum","volume":"97","author":"Wang","year":"2025","journal-title":"Anal Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znaf247","article-title":"Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the International Association of Endocrine Surgeons","volume":"112","author":"Barczy\u0144ski","year":"2025","journal-title":"Br J Surg"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2025.116196","article-title":"Permanent hypoparathyroidism following total thyroidectomy - incidence and preventative strategies without imaging adjuncts","volume":"243","author":"Niu","year":"2025","journal-title":"Am J Surg"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13959","article-title":"Effects of parathyroid hormone on renal tubular calcium and phosphate handling","volume":"238","author":"Alexander","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.07.009","article-title":"Hypoparathyroidism and the kidney","volume":"47","author":"Peacock","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1210\/endrev\/bnab005","article-title":"Physiological and pharmacological roles of PTH and PTHrP in bone using their shared receptor, PTH1R","volume":"42","author":"Martin","year":"2021","journal-title":"Endocr Rev"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.05.006","article-title":"Hypocalcemic disorders","volume":"32","author":"Bove-Fenderson","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i23.7142","article-title":"Molecular aspects of intestinal calcium absorption","volume":"21","author":"Diaz de Barboza","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab114","article-title":"Alfacalcidol vs calcitriol in the management of patient with hypoparathyroidism: a randomized controlled trial","volume":"106","author":"Saha","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B116","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ecl.2018.07.012","article-title":"Conventional treatment of hypoparathyroidism","volume":"47","author":"Babey","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030593","article-title":"The one-hundred-year anniversary of the discovery of the sunshine vitamin D3: Historical, personal experience and evidence-based perspectives","volume":"15","author":"Holick","year":"2023","journal-title":"Nutrients"},{"key":"B118","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000343104","article-title":"The history of the discovery of vitamin D and its daughter steroid hormone","volume":"61","author":"Norman","year":"2012","journal-title":"Ann Nutr Metab"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/29.11.1258","article-title":"Metabolism of vitamin D: current status","volume":"29","author":"DeLuca","year":"1976","journal-title":"Am J Clin Nutr"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1542\/peds.57.5.729","article-title":"Vitamin D: the discovery of its metabolites and their therapeutic applications","volume":"57","author":"Beale","year":"1976","journal-title":"Pediatrics"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb03821.x","article-title":"The chemistry and conformational and biological analysis of vitamin D3, its metabolites and analogues","volume":"5","author":"Norman","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19072119","article-title":"Vitamins D: Relationship between structure and biological activity","volume":"19","author":"Kutner","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00208","article-title":"Vitamin D and its synthetic analogs","volume":"62","author":"Maestro","year":"2019","journal-title":"J Med Chem"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4564","article-title":"Calcium citrate versus calcium carbonate in the management of chronic hypoparathyroidism: a randomized, double-blind, crossover clinical trial","volume":"37","author":"Naciu","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11154-020-09613-1","article-title":"Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review: Renal disease in chronic hypoparathyroidism","volume":"22","author":"Gosmanova","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B126","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1172\/JCI100224","article-title":"Studies on the physiology of the parathyroid glands: I. Calcium and phosphorus studies on a case of idiopathic hypoparathyroidism","volume":"7","author":"Albright","year":"1929","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1\u201334 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1598-x","article-title":"Present at the beginning: a personal reminiscence on the history of teriparatide","volume":"22","author":"Marcus","year":"2011","journal-title":"Osteoporos Int"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(04)90128-2","article-title":"Teriparatide: a review","volume":"26","author":"Quattrocchi","year":"2004","journal-title":"Clin Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-967088","article-title":"Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review","volume":"115","author":"Angelopoulos","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02577-x","article-title":"Chronic hypoparathyroidism and treatment with teriparatide","volume":"72","author":"Marcucci","year":"2021","journal-title":"Endocrine"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-311535.66","article-title":"Use of teriparatide in a four year old patient with autosomal dominant hypocalcaemia","volume":"101","author":"Fox","year":"2016","journal-title":"Arch Dis Child"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02128-z","article-title":"Teriparatide (rhPTH 1-34) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism","volume":"67","author":"Tuli","year":"2020","journal-title":"Endocrine"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182247b98","article-title":"Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports","volume":"92","author":"Nogueira","year":"2011","journal-title":"Transplantation"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1359","article-title":"Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism","volume":"96","author":"Linglart","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.10.5185","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1\u201334 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomized, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4188","article-title":"Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study","volume":"36","author":"Gilsenan","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116394","article-title":"Assessing the incidence of osteosarcoma among teriparatide-treated patients using linkage of commercial pharmacy and state cancer registry data, contributing to the removal of boxed warning and other labeling changes","volume":"160","author":"Kellier-Steele","year":"2022","journal-title":"Bone"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4016","article-title":"A randomized double-blind placebo-controlled first-in-human phase 1 trial of TransCon PTH in healthy adults","volume":"35","author":"Karpf","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae121","article-title":"An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism","volume":"109","author":"Takacs","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2302708","article-title":"Efficacy and safety of encaleret in autosomal dominant hypocalcemia type 1","volume":"389","author":"Gafni","year":"2023","journal-title":"N Engl J Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4274","article-title":"Safety and efficacy of oral human parathyroid hormone (1-34) in hypoparathyroidism: an open-label study","volume":"36","author":"Ish-Shalom","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae163.2320","article-title":"SAT-758 phase 1 study results of EB612, a first-in-class oral PTH(1-34) analog for the treatment of hypoparathyroidism","volume":"8","author":"Burshtein","year":"2024","journal-title":"J Endocr Soc"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae163.386","article-title":"6821 characterization of a novel oral small molecule PTH1R agonist: proof of concept for an alternative to injectable peptide-based therapy for hypoparathyroidism","volume":"8","author":"Zhang","year":"2024","journal-title":"J Endocr Soc"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910272","article-title":"Hypoparathyroidism: state of the art on cell and tissue therapies","volume":"22","author":"Miglietta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/aor.13475","article-title":"Microencapsulated parathyroid allotransplantation in the omental tissue","volume":"43","author":"Yucesan","year":"2019","journal-title":"Artif Organs"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae808","article-title":"MBX 2109, a once-weekly parathyroid hormone replacement therapy prodrug: Phase 1, first-in-human, randomized trial","volume":"110","author":"Carney","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B152","article-title":"XH02 mRNA-based PTH replacement in adults with hypoparathyroidism","year":"2025"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic mRNA applications","volume":"33","author":"\u017bak","year":"2025","journal-title":"Mol Ther"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07410-7","article-title":"Skeletal health status among patients with chronic hypoparathyroidism: Results from the Canadian National Hypoparathyroidism Registry (CNHR)","volume":"36","author":"Khan","year":"2025","journal-title":"Osteoporos Int"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjag013","article-title":"Palopegteriparatide for adults with chronic hypoparathyroidism: Skeletal dynamics through 3 yr of the phase 2 paTH Forward trial","volume":"4","author":"Rubin","year":"2026","journal-title":"J Bone Miner Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1348971","article-title":"Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: A multicenter nationwide study","volume":"15","author":"D\u00edez","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04187-x","article-title":"Impaired renal function in patients with permanent hypoparathyroidism after thyroidectomy: Analysis of a nationwide cohort in Spain","volume":"88","author":"D\u00edez","year":"2025","journal-title":"Endocrine"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03765-9","article-title":"Long-term complications of permanent hypoparathyroidism in adults: Prevalence and associated factors","volume":"84","author":"Cherchir","year":"2024","journal-title":"Endocrine"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2025.101532","article-title":"New therapeutic options in the management of chronic hypoparathyroidism","volume":"72","author":"D\u00edez","year":"2025","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1769262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:25:21Z","timestamp":1775017521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1769262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":159,"alternative-id":["10.3389\/fendo.2026.1769262"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1769262","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1769262"}}